PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA, page-42

  1. 8 Posts.
    Well done to all SH, we now have a harmonised approach on a global scale, that has been
    massively derisked. A great day, as the trials take affect and further clear this great global opportunity.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.